Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.

Oxford University academics recognised in Queen’s Birthday Honours

The pioneering work of members of the University, including research into tackling the Coronavirus pandemic, has been recognised in The Queen's Birthday Honours List.

Averting an antibiotics apocalypse: major funding announced to tackle resistance to antibiotics

A cross-disciplinary team from the Universities of Oxford, Ulster and UCL today announced major funding from EPSRC, part of UK Research and Innovation (UKRI), to tackle the growing challenge of Antimicrobial Resistance (AMR).

Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine at Oxford University have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19

The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for patients hospitalised with COVID-19.

Iron deficiency anaemia in early pregnancy increases risk of heart defects, suggests new research

In animal models, iron deficient mothers had a greatly increased risk of having offspring with congenital heart disease (CHD).

Memorial trees planted in Oxford Botanic Garden to remember lives lost to Covid-19 around the world

Health ministers from across the world have come together in a tree-planting ceremony to remember those who have tragically lost their lives to COVID-19, marking the conclusion of the G7 Health Ministers’ Meeting in Oxford on Friday 4 June.

Lack of maths education negatively affects adolescent brain and cognitive development

A new study suggests that not having any maths education after the age of 16 can be disadvantageous.

Low trust in government, conspiracy beliefs and watching YouTube predicts vaccine hesitancy

People who look to social media for information, particularly YouTube, are less willing to be vaccinated against COVID-19, according to a new publication from the universities of Oxford and Southampton whose researchers are urging the government and social media firms to take urgent action over the findings.

University of Oxford to launch Pandemic Sciences Centre

Key lesson from the coronavirus pandemic is the need for partnership between academic excellence, industry and public health organisations. Centre will unite disciplines, and sectors, to build agile, equitable partnerships that can tackle complex problems and respond to pandemic threats at any time. Centre will build on the UK and international reach of Oxford’s research collaborations.

SARS-CoV-2 RNA discovery unlocks new potential treatments

An international and multidisciplinary team led by researchers at the University of Oxford, University of Glasgow, and University of Heidelberg, has uncovered the interactions that SARS-CoV-2 RNA establishes with the host cell, many of which are fundamental for infection.

SARS-CoV-2 naming system given open platform to harness international scientific collaboration

Researchers at the Universities of Oxford and Edinburgh have announced the formalisation of the Pango Network, an international team of experts to oversee the identification and naming of different lineages of SARS-CoV-2 virus.

Oxford to play host to crucial G7 health talks

Oxford University will host the 2021 G7 Health Ministers’ Meeting in early June

Oxford University and Oracle partner to speed identification of COVID-19 variants

The partnership will enable global genomic sequencing and examination through a specialist platform developed on Oracle Cloud Infrastructure to help mitigate the impact of potentially dangerous COVID-19 variants.

Preliminary data suggests mixing Covid-19 vaccine increases reactogenicity

Research, from Com-COV study comparing mixed dosing schedules of Pfizer / Oxford-AstraZeneca vaccines, shows increase in the frequency of mild-moderate symptoms in those receiving either mixed dosing schedule. Adverse reactions were short-lived, with no other safety concerns. Impact of mixed schedules on immunogenicity unknown as yet, with data to follow from this study.

Childhood abdominal pain may be linked to disordered eating in teenagers

New research shows that people who suffer from recurrent abdominal pain in childhood may be more likely to have disordered eating as teenagers.

COVID-19 vaccine messaging that focuses on personal benefits is most effective with those who are hesitant

For the one in ten who say they won’t take a COVID-19 vaccine, messaging that focuses on personal rather than collective benefits is more effective.

Load More